GLENMARK LIFE SCIENCES share price has zoomed 7% and is presently trading at Rs 942.0.
Meanwhile, the BSE HEALTHCARE index is at 40,251.5 (down 1.4%).
Among the top gainers in the BSE HEALTHCARE index today are J.B.Chemicals (up 0.6%) and Sun Pharma (up 0.1%).
HIKAL CHEMIC (down 5.8%) and CAPLIN POINT (down 5.3%) are among the top losers today.
Over the last one year, GLENMARK LIFE SCIENCES has moved up from Rs 638.6 to Rs 942.0, registering a gain of Rs 303.4 (up 47.5%).
On the other hand, the BSE HEALTHCARE index has moved up from 27,644.7 to 40,251.5, registering a gain of 45.6% during the last 12 months.
The top gainers among the BSE HEALTHCARE index stocks during this same period were Jubilant Pharmova (up 123.6%), SUVEN PHARMACEUTICALS (up 99.2%) and GSK Pharma (up 97.3%).
Must See: These Segments are Witnessing Incredible Growth with Modi's Push
The BSE Sensex is at 78,626.9 (down 2.9%).
The top losers among the BSE Sensex today are Tata Motors (down 6.0%) and MUNDRA PORT & SEZ (down 5.1%). The most traded stocks in the BSE Sensex are Tata Steel and Tata Motors.
In the meantime, NSE Nifty is at 23,990.5 (down 2.9%). Tata Motors and ONGC are among the top losers in NSE NIFTY.
Over the last 12 months, the BSE Sensex has moved up from 66,459.3 to 78,626.9, registering a gain of 12,167.5 points (up 18.3%).
GLENMARK LIFE SCIENCES net profit fell 17.7% YoY to Rs 1,115 million for the quarter ended June 2024, compared to a profit of Rs 1,355 million a year ago. Net sales rose 1.8% to Rs 5,886 million during the period as against Rs 5,785 million in April-June 2023.
For the year ended March 2023, GLENMARK LIFE SCIENCES reported 11.5% increase in net profit to Rs 4,670 million compared to net profit of Rs 4,187 million during FY22. Revenue of the company grew 1.8% to Rs 21,612 million during FY23.
The current Price to earnings ratio of GLENMARK LIFE SCIENCES, based on rolling 12 month earnings, stands at 25.8.
Equitymaster requests your view! Post a comment on "GLENMARK LIFE SCIENCES Gains 7%; BSE HEALTHCARE Index Down 1.4%". Click here!
Comments are moderated by Equitymaster, in accordance with the Terms of Use, and may not appear
on this article until they have been reviewed and deemed appropriate for posting.
In the meantime, you may want to share this article with your friends!